Early convalescent plasma treatment may lower long COVID ris

Plasma from recovered patients, helpful in preventing severe COVID, could also decrease likelihood of post-COVID symptoms

Related Keywords

Maryland , United States , Johns Hopkins University , American , Barbara Benham , Michael Newman , Aaron Tobian , David Sullivan , Kelly Gebo , Translational Sciences , Moriah Fund , Transfusion Medicine Division , Healthnetwork Foundation , Defense Health Agency , National Institute Of Allergy , Nuclear Defense , Division Of Intramural Research , Twitter , Johns Hopkins University School Of Medicine , American Society For Microbiology , Bloomberg School , Johns Hopkins Bloomberg School Of Public Health , National Center , School Of Medicine , Mental Wellness Foundation , Shear Family Foundation , Johns Hopkins Medicine , Johns Hopkins Bloomberg School , Public Health , American Society , Johns Hopkins University School , Joint Program Executive Office , Bloomberg Philanthropies , National Institute , Infectious Diseases , Intramural Research , Advancing Translational Sciences , Octapharma Plasma , Shear Family ,